Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quantification of ALA-induced PpIX Fluorescence During Brain Tumor Resection
NCT02191488Phase 1Active, not recruiting
- Start
- Jul 2014
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 5-aminolevulinic acid in brain tumor. Primary endpoint: Comparison of intraoperative measurements of PpIX concentration to coregistered histopathology. Started Jul 2014; status: active, not recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT02191488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191488.